Biogen Canada provides update on draft recommendation supporting expanded SPINRAZA reimbursement for SMA
BIIB•A draft recommendation supports expanded public reimbursement of SPINRAZA for Canadians with SMA, but provincial funding decisions are still required and no immediate coverage changes result.
1. Provincial decisions pending
Biogen Canada said the draft recommendation does not result in immediate provincial drug coverage changes. Provincial funding decisions are still required.
